STAT Plus: What does Glaxo get with its Tesaro deal? Here’s what the wags are saying
AKIRA SUEMORI/AP
Glaxo chief executive Emma Walmsley heralded the $5.1 billion purchase of Tesaro as a “significant development” in her efforts to refocus the drug maker.
No hay comentarios:
Publicar un comentario